Argon AI, Inc.
AI for Pharma Intelligence
Operating in healthcare based in New York City, NY, USA, Argon AI, Inc. was founded in 2023.
Profile
Argon AI is a platform where biopharma and life sciences professionals can execute complex and data driven workflows using natural language. We help professionals get thorough answers to questions about clinical trials, existing treatments, healthcare landscape, and the competitive market in minutes rather than months.
Prior to starting Argon, Samy was responsible for Flatiron Health’s (Roche) first data analytics project which eventually led to the start of the Flatiron Services business unit. There, he saw first-hand the heavily manual process that biopharma companies struggle through to get the insights they need to drive forward their drug development programs. He also helped close over $6M+ in ARR and is an expert in enterprise pharma sales.
Cyrus previously led engineering teams and built 0 to 1 across pre-seed and unicorn startups, managed mission-critical trade generation systems at Bridgewater, and held AI advisory roles at various startups. Cyrus has a duel degree in EE and CS from USC.
Breakthroughs in AI present an opportunity to reinvent biopharma and life science workflows to reduce the time and cost of bringing treatments to patients where delays in bringing a drug to market can cost a pharma company $3M / day.
Argon AI, Inc. is positioned in healthcare, a segment that rewards a clear, focused offering.
New York City, NY, USA is where the company is located.
It is recorded at the Winter 2024 stage.
Its team size is recorded as 2 employees.
It has disclosed roughly $5.5M in funding.
Directory analysis
Argon AI is a startup that offers an AI‑powered platform enabling biopharma and life sciences professionals to execute complex, data‑driven workflows through natural‑language queries. The service is designed to deliver insights on clinical trials, treatments, and market landscapes in minutes rather than months, and the company was founded in 2023 in New York City with roughly $5.5 million in funding.
Positioning: Argon AI targets the pharmaceutical intelligence market, positioning itself as a rapid‑response analytics tool for clinical and commercial decision‑making. With a very small team and early‑stage capital, it is still establishing traction in a competitive AI‑healthcare landscape.
Note: Argon AI focuses on natural‑language AI for pharma analytics.
Auto-generated directory analysis from public data · updated 11 Oct 2026. Informational only, not investment advice.
| Sector | Healthcare |
|---|---|
| Headquarters | New York City, NY, USA |
| Country | USA |
| Founded | 2023 |
| Employees | 2 |
| Stage | Winter 2024 |
| Total funding | $5,515,000 |
Website: www.argon-ai.com
Browse related
Create a free account